View in EDS PDF Full Text

Choosing between CAR T-cell therapy and pirtobrutinib in double-refractory CLL.

Saved in:
Bibliographic Details
Title: Choosing between CAR T-cell therapy and pirtobrutinib in double-refractory CLL.
Authors: Rogers KA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2024 Dec; Vol. 22 (10), pp. 494-496.
Publication Type: Interview
Journal Info: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39820372
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Choosing between CAR T-cell therapy and pirtobrutinib in double-refractory CLL.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rogers+KA%22">Rogers KA</searchLink>; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101167661%22">Clinical advances in hematology & oncology : H&O</searchLink> [Clin Adv Hematol Oncol] 2024 Dec; Vol. 22 (10), pp. 494-496.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Interview
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Millennium+Medical+Pub%22">Millennium Medical Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101167661 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1543-0790 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215430790%22">15430790 </searchLink><i>NLM ISO Abbreviation: </i>Clin Adv Hematol Oncol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39820372
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 494
    Titles:
      – TitleFull: Choosing between CAR T-cell therapy and pirtobrutinib in double-refractory CLL.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rogers KA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1543-0790
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Clinical advances in hematology & oncology : H&O
              Type: main
ResultId 1